Pesticides are high-volume, widely used, environmental chemicals and there is continuous debate concerning their possible role in many chronic human health effects. Because of their known structures, known rates of application, and the presence of a large occupationally exposed population, they are not only important in their own right but are ideal models for the effects of environmental chemicals on the population in general. For reasons that are not always clear, this potential has not been realized. These exposed populations represent an underused asset in the study of the human health effects of environmental contaminants. Chronic effects thought to involve pesticides include carcinogenesis, neurotoxicity, and reproductive and development effects. In this paper we attempt to summarize this concern and, relying to a large extent on studies in our own laboratory, to indicate the importance and present status of studies of the mammalian metabolism of pesticides and indicate the need for further use of this model. Aspects considered include the role of pesticides as substrates for xenobiotic-metabolizing enzymes such as cytochrome P450 and the flavin-containing monooxygenase and their role as inducers or inhibitors of metabolic enzymes. The interaction of pesticides with complex multienzyme pathways, the role of biological characteristics, particularly gender, in pesticide metabolism, and the special role of pesticides at portals of entry and in target tissues are also considered. Environ Health Perspect 1 04(Suppl 1): 97-106 (1996) 
Introduction
As a consequence of forces acting in different directions, it is difficult to foresee the changes that will take place in pesticide toxicology as they relate not only to human health but also to the environment. Since few efforts are now being made to moderate either national or world population growth, demands for food and fiber must increase, bringing into use marginal land and marginal climatic zones. At the same time compounds useful in the production of food and fiber are lost both to pest resistance and to regulatory action. While the cost of developing new pesticides has dramatically increased, which limits such development to a small number of companies, new compounds are appearing along with questions concerning their potential for human and environmental risk. Integrated pest management, when successful, can limit the amounts of pesticides needed, but in the foreseeable future, it is unlikely to do more than slow the rate of increase in the use of these chemicals.
It is clear that pesticide toxicology is of importance in its own right, involving numerous chemicals designed to be toxic to one or more living organisms and released intentionally into the environment. At the same time, their role as model compounds for environmental chemicals in general should not be forgotten. Unlike many environmental chemicals such as combustion products, industrial waste, etc., the chemical structures of pesticides are known and they are released intentionally in amounts that are either known or can be determined. Furthermore, pesticide manufacturing workers, formulators, applicators, and agricultural workers and their families constitute a body of individuals exposed to relatively high concentrations of pesticides. Since these individuals are exposed in the course of normal, usually legal, use of pesticides, the ethical problems involved in administration of chemicals to human study groups are avoided. Studies of these groups should be an essential preliminary to consideration of the risk to the general population of the much smaller concentrations of pesticides to which they are exposed. Despite these needs and advantages, pesticides remain relatively unexplored either as important potential toxicants in their own right or as models for environmental toxicants in general. Investigators in the biochemical and molecular aspects of environmental toxicology frequently use model compounds that are either clinical drugs with little if any environmental significance or convenient chemicals, again with little or no environmental significance. In any case it remains true that in even in metabolic studies in experimental animals the isozyme specificity for pesticides, whether they are acting as substrates, inhibitors, or inducers, is largely unknown. Further, in only a vanishingly small number of cases has the role of human isozymes in pesticide metabolism been examined. The remainder of this communication is devoted to highlighting several aspects of the current state of knowledge of the interaction of pesticides with living organisms, primarily at the biochemical and molecular levels. Since space considerations preclude a detailed review of the subject, considerable emphasis is on the contributions of the authors and their associates in the area of molecular and biochemical interactions of pesticides. Knowledge of such interactions is essential for understanding mechanisms of toxicity and development of realistic risk assessment models.
Pesticides (1) (2) (3) (4) (5) are metabolized by many enzymes, including the cytochrome P450-dependent monooxygenase system (P450), the flavin-containing monooxygenase (FMO), prostaglandin synthetase, molybdenum hydroxylases, alcohol and aldehyde dehyrogenases, esterases, and a variety of transferases, most notably the glutathione S-transferases. Involved in what is usually the initial metabolic attack on the pesticide, P450 appears to be the most important, followed by the FMO. Depending upon the pesticide substrate, examples of both activation and detoxication can be found with any of these enzymes; however, P450 isozymes have added importance as activation enzymes, producing reactive electrophiles that interact with nucleophilic substituents on macromolecules such as proteins and nucleic acids. Pesticides serve not only as substrates for these enzymes but, particularly in the case of P450, may serve also as inhibitors or inducers. These multiple roles are illustrated by studies on such pesticides as the methylenedioxyphenyl synergists, organophosphates, organochlorines, and herbicide synergists (5) (6) (7) (8) .
Over 400 P450 genes have been characterized and their nucleotides and derived amino acid sequences compared. In a number of cases, the genes have been mapped to specific chromosome loci and in others the mechanism of expression has been investigated. A system of nomenclature based on derived amino acid sequences was proposed in 1987 and updated in 1989, 1991, and 1993. P450 genes are designated CYP (the protein products may still be designated P450) followed by a numbering system that distinguishes gene families, gene subfamilies, and individual genes. This system has enabled an evolutionary tree for P450s to be developed (9) . While some P450s are substrate specific, those involved in xenobiotic metabolism tend to be relatively nonspecific, although, even in the latter, substrate preferences are usually evident. Isozyme specificities also exist for inhibitors and inducers of P450 isozymes.
FMOs, like P450s, are located in the endoplasmic reticulum of vertebrate cells and are involved in the monooxygenation of pesticides. Originally described as an amine oxidase (10), FMOs are now known to catalyze the oxidation of many organic, and some inorganic, chemicals (11, 12 (32) (33) (34) (35) (36) (37) . Reproductive toxicants have the potential to cause adverse effects by one of several mechanisms. Some are direct-acting agents, either through their chemical reactivity (e.g., germ cell destruction by ionizing radiation) or by structural similarity to endogenous molecules (e.g., hormone agonists or antagonists). Other xenobiotics can interrupt reproduction indirectly either by metabolism to a direct-acting toxicant or by altering the endocrine system (e.g., increased steroid clearance).
One important mechanism of action of reproductive toxicants results from structural similarlty of the parent compound or a metabolite to an important biological molecule such as a hormone. Xenobiotics in this category then act as agonists or antagonists of the endogenous hormones. Since the early 1970s, it has been known that fetal exposure to DDT causes male animals to develop abnormally small penises and undescended testicles. For many years these effects were thought to resuk from the estrogenic action of DDT. Recent studies (38) , however, demonstrate that the primary DDT metabolite p,p'-DDE, interferes with the action of male sex hormones, or androgens, suggesting that the feminizing action of DDT resulted from the antiandrogenic action of the DDT metabolite. Has exposure to DDT and other hormonally active pesticides played a significant role in the reported increased incidence of male reproductive abnormalities in humans, such as the the reported decline in sperm counts and the rise in testicular cancer? Clearly this awaits further investigation.
Developmental Effects. Traditionally, mammalian developmental toxicity has referred to adverse effects initiated or evident during in utero development. More broadly, however, developmental toxicity also includes adverse effects on the developing organism that may have resulted from exposure of either parent before conception, of the mother during prenatal development, or postnatally to the time of sexual maturation. Development is an exceedingly complex process and the sensitivity of the conceptus to chemicals, as well as the type of abnormality expressed, varies with the developmental stage at which exposure occurs. The embryo is most vulnerable to the initiation of major birth defects between 3 weeks and 2 months of gestation, the critical period of organogenesis. Exposure to toxic chemicals during the first 2 weeks typically leads to fetal death, while exposure after organogenesis is more likely to cause growth retardation and functional deficits.
Data currently available are inadequate to make a meaningful estimate of the degree to which pesticide exposure may be involved in human developmental problems. Animal data clearly indicate that the potential is there, provided exposure occurs during sensitive time points and at sufficient concentrations. Of particular current concern is exposure to hormonally active chemicals, including pesticides. In humans and rodents, exposure to hormonally active chemicals during the period of sex differentiation can produce a wide range of abnormal sexual phenotypes including masculinized and defeminized females and feminized and demasculinized males. Xenobiotics known to act in this capacity have been referred to as environmental estrogens or environmental androgens. As mentioned in the discussion above on reproductive effects, compounds structurally similar to hormones may act either as receptor agonists or antagonists. Pesticides possessing hormonal activity and having the ability to interfere with mammalian sex differentiation include methoxychlor (39, 40) , DDT (38) , and vinclozin (41) .
The Significance of Pesticide Metabolism
Pesticides as Substrates P450 carries out many different monooxygenations of pesticide substrates, such as epoxidation (e.g., aldrin), N-dealkylation (e.g., atrazine), O-dealkylation (e.g., chlorfenvinphos), S-oxidation (e.g., phorate), and oxidative desulfuration (e.g., parathion) (8 (46) and in interactions (spectral binding and inhibition of activity) with the pesticide synergist piperonyl butoxide (47) .
Later studies (48) using highly purified P450s from phenobarbital-induced mouse livers (CYP2B) and from f-naphthoflavoneinduced mouse livers (CYPIA) showed that these induced isozymes possessed much higher levels of activity toward the organophosphates fenitrothion, parathion, and methyl parathion than did the P450 fractions purified from untreated mice, thus suggesting the importance of these P450 families in pesticide metabolism. In addition to the high level of activity, the isozymes produced different ratios of oxon (activation) to phenol (detoxication), with CYP2B forming more of the activation product than CYPIA. Similar differences in activation to detoxication ratios were found in P450 fractions from the uninduced livers. Thus the amount of toxic metabolite formed would be a function of the isozyme composition of the animal.
Studies with phorate using microsomal preparations (49, 50) (60, 61) , including the P450 monooxygenase system. The effect of MDP compounds on P450 activity is biphasic, with an initial inhibition of activity followed by an increase above control levels (50, 62, 63) . The inhibitory effect of MDP compounds has been attributed to the formation of a stable inhibitory metabolite complex between the heme iron of the P450 and the carbene species formed when water is cleaved from the hydroxylated methylene carbon of the MDP compound (64) . MDP exposure induces several P450 isozymes not found in detectable quantities in unexposed animals (65) (66) (67) (68) (65) . Some investigators have reported that CYPlAI is also induced in mice by MDP compounds (71) . In induction studies in rats using 4-n-alkyl MDPs, the length of the alkyl side chain affected which P450 isozymes were preferentially induced, with the six-carbon side chains favoring 2B 1; the rat P450 was most similar to mouse 2B 10 (71). In another study, MDP compounds with electron-donating side chains were reported to be P450 inducers while MDP compounds with electron withdrawing groups were not (72) .
Regulation of cytochrome P450 isozymes lAl, 1A2, and 2B10 by MDP compounds was studied in our laboratory by measuring mRNA and protein levels, as well as enzyme activities in hepatic tissue, from C57BL/6 (Ah+) and DBA/2 (Ah-) mice dosed with ISO or PBO (66) (67) (68) . Increases in 1A2 and 2B10 were observed for ISO and PBO in both stains of mice, suggesting an Ah receptor-independent mechanism for induction of these isozymes; lAI induction, however, was seen only in C57 mice and only at high doses of PBO. Dose-response studies showed maximum inducible levels for 1A2 and 2B10 protein, beyond which the mRNAs continued to increase while the protein levels remained constant.
Further studies of the induction of the P450 isozymes lAl, 1A2, and 2B10 were carried out (66-68) using four MDP compounds (SAF, ISO, PBO, and SES) and the non-methylenedioxyphenyl analog of SAF, allyl benzene, in male C57BL/6N mice. CYPlAl was not detected in control animals and was induced by SES and PBO, with SES inducing higher levels of lAl protein than PBO. CYP1A2 mRNA was detected in the livers of control animals and was increased by all MDP compounds (SES > PBO ISO > SAF). Allyl benzene treatment did not induce detectable levels of lAI, 1A2, or 2B10, suggesting that the methylenedioxy moiety is important in induction.
Recent studies (73) , using the closely related benzodioxoles 5-t-butyl-1,3-benzodioxole; 5-n-butyl-1,3-benzodioxole; and 5-(3-oxobutyl)-1,3-benzodioxole, have further defined the involvement of this class of compounds in the regulation of P450 isozymes, confirming that even in the Ah+ C57BL/6 strain of mice, none of these compounds induced CYPlAI. All three benzodioxoles induced protein and mRNA message for CYPIA2, while the t-butyl analog also induced both protein and message for CYP2B10.
Thus all of the studies of the effects of methylenedioxyphenyl compounds on cytochrome P450 in mice suggest that CYP1A2 can be induced by a non-Ah receptor-dependent mechanism as well as by an Ah-dependent mechanism. This is currently being explored.
Tridiphane. The herbicide synergist tridiphane [2-(3,5-dichlorophenyl)-2-(2,2,2-trichloroethyl) oxirane] is a postemergent herbicide used in conjunction with atrazine, its activity being attributed to its ability to inhibit glutathione S-transferases. Tridiphane is also known to be a peroxisome proliferator and to induce epoxide hydrolase in rodents (74) .
Tridiphane is an excellent example of a pesticide that can function both as an inhibitor and an inducer of cytochrome P450, with different isozymes specificities for each activity. Induction of CYP4A protein and associated enzyme activity has been demonstrated (75) . The CYP4A enzymes are constitutive proteins known to be involved in the oi-hydroxylation of medium-and long-chain fatty acids. The importance of peroxisome proliferation in human health has yet to be clearly defined because many aspects of this phenomenon appear to be rodent specific. Nevertheless, until the effect has been defined, it is not something that should be ignored.
Endogenous Effets
Many studies have While it has long been known that the FMO activity toward several substrates was higher in the liver of female than of male mice, these studies were carried out at the level of substrate oxidation and before it was known that several different isoforms of FMO exist in mammals. Hepatic FMO activity of microsomes from adult CD-1, Swiss-Webster, C57BL/6, and DBA/2 mice was found, in all cases, to be significantly higher in females than in males. Based on protein and mRNA levels in CD-I mice, it was shown that the isoforms responsible for this difference were FMO1 and FMO3; FMO5 was the same in the livers of mice of either gender. FMO1 was 2 to 3 times higher in female liver than in male liver while FMO3, expressed at levels similar to those of FMO1 in females, was not detected in the liver of males. There was close correlation between protein levels and mRNA levels in each case. Thus, in mouse liver there is a gender-independent isoform (FMO5), a gender-dependent isoform (FMO1), and a gender-specific isoform (FMO3). Neither FMO2 nor FMO4 was detected in the liver of mice or either gender. This effect, while dramatic, is tissue dependent. FMO1, FMO3, and FMO5 are expressed at similar levels in the lung and kidney of CD-I mice of both genders.
Pesticides as Inhibitors
There are several mechanisms by which pesticides may act to inhibit P450 enzymes: competitive inhibition, whereby the pesticide competes with the substrate at the active site, thus preventing substrate binding (the pesticide may or may not also be a substrate); noncompetitive inhibition in which the pesticide binds to the enzyme in such a way as to alter the activity of the enzyme toward its substrate; and suicide inhibition, whereby the pesticide is metabolized by the enzyme and a metabolite of the pesticide binds to the enzyme, irreversibly inhibiting its activity.
As mentioned earlier, MDP compounds have very complex interactions with the P450 system (50, (60) (61) (62) (63) (64) (65) (66) (67) (68) (69) (70) (71) (72) (73) . Since MDP compounds are substrates for P450 enzymes, they may act initially as competitive inhibitors. In vitro with microsomal systems, this interaction is manifested as a type I binding spectrum with a peak at 390 nm and a trough at 420 nm. As the MDP compound is metabolized, it becomes a suicide inhibitor, which as a reactive metabolite (probably a carbene) forms a stable inhibitory complex with the heme iron of P450. It is this latter characteristic that is responsible for the synergistic activity of these compounds, most notably piperonyl butoxide, in pesticide formulations.
As noted above, the herbicide synergist tridiphane is a postemergent herbicide, and its activity is attributed to its ability to inhibit glutathione S-transferases.
Environmental Health Perspectives * Vol 104, Supplement * March 996 Tridiphane has been shown to induce peroxisome proliferation, epoxide hydrolase (74) , and P450 (75) in rodents. In addition to induction of CYP4A, tridiphane functions as a selective P450 inhibitor, inhibiting CYP2B10 while having little or no effect on other P450 isozymes (77) . As assessed by in vitro studies, tridiphane appears to be a competitive inhibitor of the P450 enzymes; its effect in vivo, however, is not yet known.
Organophosphorus insecticides such as parathion that contain the P = S moiety are metabolized by the P450 system to the corresponding oxon, P = 0, by oxidative desulfuration. This activation reaction, which converts the relatively inactive compound to a potent cholinesterase inhibitor, is thought to involve the formation of a P-S-O (phosphooxythirane) ring intermediate. Studies with both microsomes and purified enzymes (78-80) have demonstrated that, during oxidatiye desulfuration, the released sulfur exists as a highly reactive molecule which then binds to P450, inactiviting the enzyme. This binding of reactive sulfur to P450 is accompanied by loss of P450 as detected by measurement of the dithionite-reduced CO complex as well as loss of monooxygenase activity (81) (82) (83) (84) . Studies in our laboratory with purified P450s and the pesticide fenitrothion demonstrated that the amount of inhibition varied with the P450 isozyme, with CYP2B being inhibited more than CYPlA (48).
Pesticides in Complex Multienzyme Pathways
General Approach While P450 and FMO have many substrates in common, the products of these substrates may be different and have different toxic potencies. Thus, it is important to know the relative contribution of the two pathways to the metabolism of a particular substrate. Furthermore, in contrast to FMO isozymes, xenobiotic-metabolizing isozymes of P450 are often relatively easily induced, thus making the relative contributions variable with the conditions of exposure. Although it is said that the FMO prefers soft nucleophiles as substrates and P450 hard nucleophiles, with the exception of compounds oxidized at carbon atoms, this applies only to the relative ability of compounds to serve as substrates for one or the other because it is difficult to find FMO substrates that are not also substrates for one or more P450 isozymes.
Such substrates may have complex oxidation patterns involving both FMO and P450 isozymes and show different regioselectivity in the sites on the molecule attacked. As a result, these substrates may yield different products or different isomers of the same product. A number of methods are available for determining the relative contributions of FMO and P450 including extrapolation from the properties of purified enzymes (or from isozymes cloned and expressed in expression systems), the use of product-specific substrates, the use of enzyme-specific substrates, or the manipulation of microsomes in which both enzymes are found. This latter technique, using heat treatment to inactivate FMO or an antibody to the NADPH-P450 reductase to inactivate P450, has proven most useful in our hands, particularly in the case of hepatic enzymes (42, 49, 50, 85) . At least one of the FMO forms found in the lung and kidney is resistant to thermal interaction. This form, however, is not expressed in liver.
Phorate. The insecticide phorate undergoes a complex series of oxidations. The products are generally more toxic than phorate and the reaction sequence is, therefore, an activation sequence. This substrate has proven to be useful in examining the relationship between FMO and P450 activity.
FMO forms only one product, phorate sulfoxide, while P450 yields phorate sulfoxide as well as additional products. Moreover, the sulfoxidation reaction is stereospecific with FMO producing the (-) sulfoxide and several P450 isozymes the (+) sulfoxide. While both sulfoxide isomers are substrates for further metabolism by all P450 isozymes tested, the (+) sulfoxide is always preferred to the (-) sulfoxide (45) . The relative contribution of FMO to sulfoxide formation is higher in female than in male mice, in agreement with the studies of gender effects described above. Although overall sulfoxide formation is higher in the liver than in any extrahepatic tissue, the contribution of the FMO relative to P450 is higher in lung, kidney, and skin-being as high as 90% of the total metabolism in renal microsomes from the female mice. By contrast in the liver, P450 is responsible for more of the phorate sulfoxidation (-50-70%, depending upon the gender). Furthermore, the contribution of P450 relative to FMO is increased following treatment in vivo with inducers of hepatic P450 such as phenobarbital (49, 50) .
Target Tissues
Nervous System. Initial studies in this area in our laboratory involved the antipsychotic drug thioridazine (TDZ). They are currently being extended to include pesticide substrates. Many drugs, including antipsychotics, monoamine oxidase inhibitors, and antihistamines, are substrates for the FMO; TDZ is an excellent substrate for examining the relative importance of different oxidative pathways because it is oxidized at multiple sites by both FMO and P450.
Based primarily on examination of urinary and serum metabolite profiles, S-oxidation appears to be the predominant route of TDZ, metabolism in humans by producing the 2-sulfoxide, the 2-sulfone, and the 5-sulfoxide. The 2-sulfoxide and the 2-sulfone are known to have greater antipsychotic activity than the parent compound, while the ring sulfoxides may be responsible for the cardiotoxic side effects sometimes seen with TDZ [see Hodgson et al. (4, 5) for review].
Metabolism by hepatic microsomes from the mouse yielded primarily the 2-sulfoxide of TDZ, with significant amounts of the 5-sulfoxide, the N-oxide, the N-demethyl derivative, and the 2-sulfoxide-N-oxide (86) . Heat treatment of microsomes to selectively destroy the FMO activity or treatment with an antibody to the NADPH-cytochrome P450 reductase to inhibit P450 isozymes revealed that the N-oxide was the principal metabolite derived from the FMO, while the 2-sulfoxide and the other products were derived primarily from one or more isozymes of cytochrome P450.
Studies using FMO purified from mouse liver have shown the N-oxide of TDZ to be the principal and perhaps the only product of TDZ metabolism by this enzyme. Similar experiments using P4502D6 revealed that the 2-sulfoxide of TDZ (mesoridazine) is the principal but not the only metabolite of TDZ with this P450 isozyme. Similar experiments have been carried out with P450 isozymes 2E1 and 2B1.
The possible occurrence and role of FMO in the nervous system appears to be important not only because TDZ and several of its metabolites have similar biological properties and activation within the target tissue may be significant but also because the FMO has been shown to activitate phosphonates by metabolism to their oxons (43, 87, 88) 
Portals of Entiy
Skin. Because the skin is continuous over the large surface area of the body and is in direct contact with the environment, it is often the portal of entry for pesticides and other environmental contaminants, as well as the site of transdermal absorption of clinical drugs. Thus, knowledge of the enzymes involved in xenobiotic metabolism by skin is important for understanding mechanisms of toxicity and for developing more realistic risk assessment models (93) . The skin is known to contain many of the xenobiotic metabolizing enzymes found in the liver, including P450, transferases, esterases, and epoxide hydrolase (94) (95) (96) (97) (98) . Moreover, P450 activity in skin has been shown to be induced by polycyclic aromatic hydrocarbons such as 3-methylcholanthrene and other xenobiotics (99) (100) (101) (102) (103) .
We have recently studied pesticide substrates in mouse skin (44) . In these studies the roles of P450 and FMO were studied in skin microsomes and compared to those in liver. The P450 content of skin was approximately 6.8% of the liver P450 content. By comparison, NADPH-cytochrome c reductase activity in skin microsomes was high-approximately one-third of the liver microsomal enzyme activity. Skin microsomes metabolized several known P450 substrates and, depending upon the substrate used, the specific activity ranged from 2.5 to 13.4% of the corresponding rates seen in liver microsomes. Skin microsomes exhibited the highest enzymatic activity with benzo[a]pyrene and ethoxyresorufin, moderate activity with parathion and aldrin, and low activity with benzphetamine and ethoxycoumarin. Skin microsomes also metabolized the triazine herbicides atrazine, simazine, and terbutryn, with the activity being 2 to 5% of the liver microsomal activity. FMO activity in skin microsomes with thiobenzamide and methimazole as substrates ranged from 10 to 20% of the liver FMO activity. Immunohistochemical studies using antibodies to mouse liver FMO showed localization primarily in the epidermis. Additional studies using pig skin showed a similar distribution pattern. Antibodies developed to mouse liver FMO and the constitutive liver P450 isozyme CYP1A2 showed cross-reactivity on Western blots; proteins in skin microsomes appeared identical to the cross-reacting protein present in liver microsomes. The relative contribution of P450 and FMO in mouse skin to the sulfoxidation of phorate was investigated and compared to that of liver microsomes. Several procedures were employed to selectively inhibit either P450 or FMO so that the role of each monooxygenase system, in the absence of the other system, could be determined. As in the lung and kidney, FMO in the skin proved to be relatively more important than P450 for the sulfoxidation of phorate. In liver microsomes, P450 was responsible for 68 to 85% of the phorate sulfoxidation activity. In contrast in skin microsomes, 66 to 69% of the phorate sulfoxidation activity was due to FMO, while P450 was responsible for the remainder of the activity. Although the overall phorate sulfoxidation rate in mouse skin microsomes was only 3 to 4% of the rate seen in liver, FMO appears to assume a greater role relative to P450 in the metabolic processes in skin.
While microsomal systems isolated from skin have provided useful information on skin biotransformation, there has been a need for more useful experimental models to examine cutaneous metabolism. The isolated perfused porcine skin flap (IPPSF) has been shown to represent a viable, fully functional, and predictive in vitro model system (104, 105) . Drugs, pesticides, and other xenobiotics that are applied topically to the IPPSF diffuse through the layers of the skin, and the chemical and its metabolites are taken up by the microcirculation, which closely mimics in vivo conditions. In addition, the test chemical may be administered intra-arterially to examine the fate of chemicals that distribute to the skin from the systemic circulation. We have used this model to study the metabolism and disposition of topically applied parathion (105) . Parathion was applied to the surface of skin flaps representing three treatment groups: control, occluded, and 1-aminobenzotriazole (ABT)-pretreated. Radiolabel uptake in the perfusion medium indicated that total chemical flux and peak rates of absorption in occluded preparations were 59% and 47% lower than in controls, respectively, and both were > 75% lower in the ABT flaps. Most of the absorbed radiolabel recovered in the perfusion medium of the control group was paraoxon (68%); there was a lesser amount of p-nitrophenol (1 5%), and the remainder was unmetabolized parathion. Occlusion of the application site increased the fraction of p-nitrophenol (43%) to that of paraoxon (40%) without altering the parent compound recovered. Pretreatment of the IPPSF with ABT (an inhibitor of P450) blocked most of the paraoxon formation (7%) but not that of p-nitrophenol (12%), while allowing 78% of the parathion absorbed to penetrate intact. These findings show that parathion undergoes significant biotransformation following topical application to porcine skin and that the resultant cutaneous metabolite profiles can be altered by both physical (occlusion) and chemical (ABT) means.
As indicated above in the case of mirex, pesticides passing through the skin can also be shown to affect the expression of P450 human health must be more extensive if significance is to be properly assessed. Companion toxicological studies will be necessary to provide a mechanistic basis for the correlations observed. Similarly, exposure assessment will need to be continued. In both cases, the occupationally exposed provide a useful pool to yield initial insights before the much more intractable problem of the general population is addressed.
The interactions of pesticides with P450, FMO, and other Phase I and Phase II enzymes have been studied for some time; however, isozyme specificity for metabolism, induction, and inhibition is still little understood. If toxicology is to serve the public interest by carrying out the kinds of studies that protect public health but, at the same time, allow efficient vector control and the production of food and fiber, a more holistic approach will be necessary. It is not sufficient to know whether an agricultural chemical is a substrate for microsomal oxidation. A number of other questions must be addressed: What are the specific enzymes and isoforms involved? Is the reaction an activation or a detoxication reaction? Does induction or inhibition occur? What is the relationship to other Phase I and Phase II enzymes? How are these relationships changed by other xenobiotics? What interactions occur at portals of entry and sites of toxic action? Can this information be integrated into risk assessments and provide a mechanistic rationale for epidemiological studies? Only with this type of fundamental information can applied problems in the field be addressed.
